“borderline significant”

The difference in TPO protein expression between normal tissue and cancer samples was borderline significant ( P -value = 0.05).

A borderline significant difference in the probability of neovascular activity for predominantly hyperdense lesions compared to hypodense lesions was detected ( p =0.05).

Our results showed a borderline significant difference between the two groups regarding 5STS ( p = 0.05).

Statistical analyses between groups A and B revealed that mean age at the diagnosis of thyroid cancer was higher in patients of group B and this difference was borderline significant (t = -1.95, p = 0.05).

The online ward, but not the F2F or control wards showed increased number of good diabetes days (GDD) from median (IQR) 4.7 (2.7–7.0) at baseline/rollout to 6.0 (2.3–7.0) in the post-intervention phase ( p = 0.04), along with increased hypos treated appropriately by ward staff (80% vs 85%, p = 0.026) and total hypos (10% vs 16%, p = 0.043), while severe hypos was borderline significant (3% vs 6%, p = 0.05).

Further, FR-QoL-29 scores were significantly positively correlated, though weakly, with serum albumin levels (Spearman’s rank, n=279, r s =0.13, p=0.03) and a borderline significant inverse correlation was found between FR-QoL-29 scores and age (Spearman’s rank, n=301, r s =−0.11, p=0.05) ( online supplemental figures 7 and 8 ).

A borderline significant correlation was present when exciting with 440 nm (r = 0.57, p = 0.05) and 750 nm (r = 0.55, p = 0.06).

There was a borderline significant overall effect of treatment ( F 1, 1.18 = 82.59, P = 0.05).

The second measure of self-reported anxiety (SCARED) also revealed a borderline significant change over time [ F (2, 12) = 3.41, p = 0.050].

In the patient group, response times to addition sums that bridged a decade (M = 4431.18, SD = 4197.4) showed a borderline significant difference from those addition sums that did not bridge a decade (M = 3698.98, SD = 3765); standardized test statistic = −1.96, n = 9, p = 0.05.

Furthermore, SGB also demonstrated a borderline significant reduction in pain scores at 24 hours (MD = −0.48; 95% CI = −0.96, −0.01; P = 0.05; I 2 = 67%, Figure 7 ).

Compared with VKAs, the use of DOACs was associated with significantly reduced risks of stroke (RR = 0.56, 95% CI 0.45-0.70; p < 0.00001), ischemic stroke (RR = 0.61, 95% CI 0.48-0.78; p < 0.0001), stroke or systemic embolism (SSE) (RR = 0.81, 95% CI 0.68-0.95; p = 0.01), myocardial infarction (RR = 0.69, 95% CI 0.55-0.88; p = 0.002), major bleeding (RR = 0.75, 95% CI 0.63-0.90; p = 0.002), intracranial hemorrhage (RR = 0.50, 95% CI 0.44-0.56; p < 0.00001), and major gastrointestinal bleeding (RR = 0.77, 95% CI 0.62-0.95; p = 0.02), and a borderline significant decrease in major adverse cardiac events (RR = 0.87, 95% CI 0.75-1.00; p = 0.05) in NVAF patients with diabetes.

The difference in mean triglyceride level in the placebo group was not significant after the intervention, although there was a borderline significant difference in the intervention group (p=0.05); nevertheless, the changes in mean triglyceride level between the two groups did not indicate a significant difference.

The model including ART, maternal age and height, primiparity, labor and multiple gestation was borderline significant (adjusted R 2 0.112, p = 0.05) and ART and multiparity were the only statistically significant contributors to the variance of CDKN1C levels.

Coffee with added sugar showed a significant positive correlation with Bifidobacterium (IVW method: OR = 1.56, 95% CI : 1.05-2.33, P = 0.03) and a borderline significant negative correlation with Veillonella (IVW method: OR = 0.65, 95% CI : 0.423–0.99, P = 0.05).

There was a slight increase in the odds of having ocular surface symptoms after adjusting for age and gender, but it was borderline significant (OR: 4.28, 95% CI, 0.93-19.58, p = 0.05) Of the 74 subjects identified as having symptoms of ocular surface disorders according to the OSDI score, only 16 were identified as abnormal by the Schirmer’s test.

Despite a borderline significant reduction in Gls2 relative abundance ( p < 0.05)—which may be attributed to a slight elevation in one Δ pan2 Δ pan3 replicate—the markedly lower abundance of the fused proteins in Δ pan2 Δ pan3 versus WT is consistent with expected regulation by the Pan complex (Figure 7G–I ).

The results also displayed a borderline significant difference across the genetic risk scores for body fat mass (p = 0.05), percentage of body fat (p = 0.05), serum HDL concentration (p = 0.08), and CRP (p = 0.06).

The Constant scores also showed more improvement in group S&P than group S at 2 years after surgery, but the mean difference in scores was borderline significant (13.4 vs 9.9, respectively; P = .050).

However, there were significant differences ( p < 0.05) in age, education, and years of experience (work tenure), and a borderline significant difference in gender between groups ( p = 0.050).

When all inflammation markers, significantly associated with breast cancer, were included together in the same model (model I) the risk estimates remained similar (i.e., the effects seemed to be independent of each other), but the association was only borderline significant for IL-1β (p = 0.05).

A borderline significant difference was observed between subgroups based on stimulant type ( p = 0.05).

For RNFL thickness, the adjusted effect was borderline significant ( p ≈ 0.05).

The largest association was a borderline significant reduction in lower back pain with each hour reduction in prolonged sitting ( b = −0.39, 95% CI: −0.79, 0.00, p = 0.050).

SBP was borderline significant for predicting adverse CV events (p = 0.05).